Kimuratan Corporation
Kimuratan Corporation (8107.T) Financial Performance & Income Statement Overview
Review Kimuratan Corporation (8107.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Kimuratan Corporation (8107.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Kimuratan Corporation 8107.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $456.00M | $690.00M | $306.00M | $306.00M |
| Cost of Revenue | $313.00M | $456.00M | $161.00M | $157.00M |
| Gross Profit | $143.00M | $234.00M | $135.02M | $149.00M |
| Gross Profit Ratio | $0.31 | $0.34 | $0.44 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $98.00M | $161.00M | $148.00M | $128.00M |
| Operating Expenses | $110.00M | $151.66M | $138.23M | $129.00M |
| Total Costs & Expenses | $423.00M | $617.00M | $309.00M | $286.00M |
| Interest Income | $0.00 | $48000.00 | $0.00 | $0.00 |
| Interest Expense | $29.00M | $30.05M | $19.95M | $17.00M |
| Depreciation & Amortization | $56.00M | $62.75M | $56.72M | $62.75M |
| EBITDA | $112.00M | $135.75M | $53.00M | $83.75M |
| EBITDA Ratio | $0.25 | $0.20 | $0.17 | $0.27 |
| Operating Income | $33.00M | $73.00M | -$3.00M | $20.00M |
| Operating Income Ratio | $0.07 | $0.11 | -$0.010 | $0.07 |
| Other Income/Expenses (Net) | -$8.00M | -$33.00M | -$29.00M | -$32.00M |
| Income Before Tax | $25.00M | $40.00M | -$32.00M | -$12.00M |
| Income Before Tax Ratio | $0.05 | $0.06 | -$0.10 | -$0.04 |
| Income Tax Expense | $10.00M | $31.00M | $5.00M | $3.00M |
| Net Income | $16.00M | $9.00M | -$37.00M | -$15.00M |
| Net Income Ratio | $0.04 | $0.01 | -$0.12 | -$0.05 |
| EPS | $0.06 | $0.04 | -$0.15 | -$0.06 |
| Diluted EPS | $0.06 | $0.04 | -$0.15 | -$0.06 |
| Weighted Avg Shares Outstanding | $255.67M | $254.97M | $246.66M | $243.15M |
| Weighted Avg Shares Outstanding (Diluted) | $255.67M | $254.97M | $246.66M | $243.15M |
Financial performance has remained strong, with revenue growing from $306.00M in Q1 2024 to $456.00M in Q4 2024. Gross profit continued to perform well, with margins at 31% in the latest quarter. Operating income reached $33.00M in Q4 2024, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $112.00M. Net income rose to $16.00M, keeping EPS at $0.06. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan